Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (81-90 of 541) with videos related to

Pageof 55
Sort By:
ESC Heart Failure|July 1, 2020
Hyperkalaemia and hypokalaemia outpatient management: a survey of 500 French general practitionersLaure Abensur Vuillaume, Patrick Rossignol, Zohra Lamiral, et al.
Journal of Cardiac Failure|October 16, 2022
High- Versus Low-dose Losartan and Serum Potassium: An Analysis From HEAALJoão Pedro Ferreira, Marvin Konstam, Patrick Rossignol, et al.
Clinical Kidney Journal|April 4, 2022
Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal riskJoão Pedro Ferreira, Faiez Zannad, Scott D Solomon, et al.
Journal of the American College of Cardiology|October 29, 2011
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudyPatrick Rossignol, Joël Ménard, Renaud Fay, et al.
Pharmacoepidemiology and Drug Safety|July 25, 2019
Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort studySarah Bitar, Nelly Agrinier, François Alla, et al.
American Journal of Nephrology|November 30, 2016
High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60João Pedro Ferreira, Nicolas Girerd, Bruno Pannier, et al.
Ultrasound in Medicine & Biology|November 20, 2004
Compliance of abdominal aortic aneurysms: evaluation of tissue Doppler imagingAnne Long, Laurence Rouet, Alvine Bissery, et al.
European Journal of Heart Failure|March 2, 2026
Mineralocorticoid receptor antagonists reduce new-onset atrial fibrillation across the cardio-kidney-metabolic spectrum: a meta-analysis of randomized clinical trialsPedro Marques, Francisco Vasques-Nóvoa, Faiez Zannad, et al.
The Journal of Emergency Medicine|July 22, 2019
Hyperkalemia in the Emergency Department: Urgent Need for a Rigorous Evaluation of the First-Line TreatmentsLoic Lemoine, Tahar Chouihed, Matthieu Legrand, et al.
International Urology and Nephrology|July 15, 2020
Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primerSidar Copur, Alan A Sag, Baris Afsar, et al.
Pageof 55

Showing results (81-90 of 541) with videos related to

Sort By:
Pageof 55
ESC Heart Failure|July 1, 2020
Hyperkalaemia and hypokalaemia outpatient management: a survey of 500 French general practitionersLaure Abensur Vuillaume, Patrick Rossignol, Zohra Lamiral, et al.
Journal of Cardiac Failure|October 16, 2022
High- Versus Low-dose Losartan and Serum Potassium: An Analysis From HEAALJoão Pedro Ferreira, Marvin Konstam, Patrick Rossignol, et al.
Clinical Kidney Journal|April 4, 2022
Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal riskJoão Pedro Ferreira, Faiez Zannad, Scott D Solomon, et al.
Journal of the American College of Cardiology|October 29, 2011
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudyPatrick Rossignol, Joël Ménard, Renaud Fay, et al.
Pharmacoepidemiology and Drug Safety|July 25, 2019
Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort studySarah Bitar, Nelly Agrinier, François Alla, et al.
American Journal of Nephrology|November 30, 2016
High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60João Pedro Ferreira, Nicolas Girerd, Bruno Pannier, et al.
Ultrasound in Medicine & Biology|November 20, 2004
Compliance of abdominal aortic aneurysms: evaluation of tissue Doppler imagingAnne Long, Laurence Rouet, Alvine Bissery, et al.
European Journal of Heart Failure|March 2, 2026
Mineralocorticoid receptor antagonists reduce new-onset atrial fibrillation across the cardio-kidney-metabolic spectrum: a meta-analysis of randomized clinical trialsPedro Marques, Francisco Vasques-Nóvoa, Faiez Zannad, et al.
The Journal of Emergency Medicine|July 22, 2019
Hyperkalemia in the Emergency Department: Urgent Need for a Rigorous Evaluation of the First-Line TreatmentsLoic Lemoine, Tahar Chouihed, Matthieu Legrand, et al.
International Urology and Nephrology|July 15, 2020
Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primerSidar Copur, Alan A Sag, Baris Afsar, et al.
Pageof 55